Chinese Labs Are Writing the Next Decade of Drug Discovery. Who Keeps the Money?
A $139 billion year of out-licensing shifts the question from who discovers drugs to who captures the economics.
A $139 billion year of out-licensing shifts the question from who discovers drugs to who captures the economics.
October 15, 2026 Bonus Content: Union Pacific’s Intermodal Machine Is Running Hotter Than Wall Street Realizes A note from our…
October 15, 2026 Ukraine’s Starlink limits exposed a risk SPCX and TSLA investors should weigh. On the night of October…
Dow’s bio-circular polyethylene push is real and accelerating, but the feedstock economics and a $21 billion market cap tell a more complicated story.
October 15, 2026 Bonus Content: Merck, AbbVie, and Pfizer All Gained 4% Yesterday. How to Own the Rotation Without Chasing…
Ukraine’s Starlink limits exposed a risk SPCX and TSLA investors should weigh.
October 15, 2026 Bonus Content: Nvidia Still Leads China’s AI Chip Market. The Gap Is Closing. A note from our…
October 14, 2026 The ZO Skin Health deal shows where durable consumer spending is hiding, and which public companies sit…
David Solomon used the Q3 earnings call to shut down succession rumors, days after $500 million in executive stock awards.
October 14, 2026 Bonus Content: Nvidia Is Pouring $10 Billion Into Europe. What It Says About Demand. A note from…